Indefinite Delivery Contract 75D30122D13471
Award Date
4/1/22
Last Date to Order
3/31/23
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to support the Vaccines for Children program and Section 317(j) of the Public Health Service Act. The prime contractor is Sanofi Pasteur Inc. The contract has a potential value of $1.537 billion and a period of performance from April 1, 2021 through March 31, 2022.
Under this IDV, the contractor will provide 20 standard pediatric vaccines to support...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Sanofi Pasteur Inc. to procure a range of pediatric vaccines over a 1-year period of performance from April 1, 2024 through March 31, 2025. The $1.79 billion contract seeks to purchase between 100 doses and 13 million doses each of 27 different vaccines, including influenza, meningitis, pneumonia, and other standard...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. The 5-year contract, valued at a ceiling of $1,996,408,200.00, is for the provision of standard commercial pediatric vaccines to support the Vaccines for Children (VFC) program. As the prime contractor, Sanofi Pasteur Inc. will be required to deliver a variety of vaccine types to CDC distribution centers within 15 working days,...
The federal contract IDV award is an Indefinite Delivery Contract held by Pfizer Inc. for the Centers for Disease Control and Prevention (CDC) Vaccines for Children (VFC) program. The contract has a ceiling value of $2,007,801,000.00 and a period of performance from April 1, 2025, through March 30, 2026.
Under this IDV, Pfizer will provide a range of standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022.
The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...
This federal contract IDV is awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to procure a range of pediatric vaccines for the agency's Immunization Awardees program and Vaccines for Children program. The 5-year, $1.3 billion multiple award contract enables the CDC to purchase between 100 doses and 13 million doses of 27 different pediatric vaccines from the prime contractor, Glaxosmithkline, LLC. The vaccines...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. for the purchase of 27 different pediatric vaccines to support the CDC's Immunization Awardees program and Vaccines for Children program. The contract has a period of performance from April 1, 2024 to March 31, 2025 and a ceiling value of $1,914,795,500.00.
The solicitation sought offers for the supply of...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor.
Sanofi Pasteur, as a leading global vaccine manufacturer, will...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a global pharmaceutical company, to provide a range of pediatric influenza vaccines. The 5-year contract, valued at up to $163,144,080, covers the period from December 31, 2024 to February 28, 2026. As the prime contractor, Sanofi Pasteur will leverage its manufacturing and distribution capabilities to fulfill task orders for seasonal and pre-pandemic influenza...